Elevated levels of cGAS-STING signaling components, including cGAS, STING, and IRF3, have been observed in both human NAFL and NASH patients, as well as in high-fat diet (HFD) or NASH mouse models (9, 114). The gene discussed is STING1; the disease is metabolic dysfunction-associated steatohepatitis.